Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00376181

Public ClinicalTrials.gov record NCT00376181. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 9:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Determine the Efficacy, Safety, and Tolerability of AD-4833-536 in the Treatment of Subjects With Type 2 Diabetes

Study identification

NCT ID
NCT00376181
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
96 participants

Conditions and interventions

Interventions

  • Pioglitazone and Azilsartan Drug
  • Pioglitazone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
Jun 21, 2010

2006 – 2007

United States locations

U.S. sites
59
U.S. states
21
U.S. cities
59
Facility City State ZIP Site status
Not listed Huntsville Alabama
Not listed Tallassee Alabama
Not listed Little Rock Arkansas
Not listed Auburn California
Not listed Bakersfield California
Not listed Buena Park California
Not listed Chula Vista California
Not listed Huntington Park California
Not listed Los Gatos California
Not listed Norwalk California
Not listed Orangevale California
Not listed Sacramento California
Not listed Stockton California
Not listed Deerfield Beach Florida
Not listed Hialeah Florida
Not listed Hollywood Florida
Not listed Jacksonville Florida
Not listed Kissimmee Florida
Not listed Marianna Florida
Not listed Melbourne Florida
Not listed Miami Florida
Not listed Pembroke Pines Florida
Not listed Winter Haven Florida
Not listed Augusta Georgia
Not listed Dunwoody Georgia
Not listed Chicago Illinois
Not listed Bloomington Indiana
Not listed Evansville Indiana
Not listed Shawnee Mission Kansas
Not listed Prince Frederick Maryland
Not listed Livonia Michigan
Not listed Saint Clair Shores Michigan
Not listed Las Vegas Nevada
Not listed Trenton New Jersey
Not listed Albany New York
Not listed Johnson City New York
Not listed Staten Island New York
Not listed Charlotte North Carolina
Not listed Salisbury North Carolina
Not listed Winston-Salem North Carolina
Not listed Marion Ohio
Not listed Oklahoma City Oklahoma
Not listed Buckingham Pennsylvania
Not listed Jeannette Pennsylvania
Not listed Mt. Pleasant South Carolina
Not listed Simpsonville South Carolina
Not listed Bristol Tennessee
Not listed New Tazewell Tennessee
Not listed Dallas Texas
Not listed El Paso Texas
Not listed Euless Texas
Not listed Fort Worth Texas
Not listed Houston Texas
Not listed McKinney Texas
Not listed Midland Texas
Not listed North Richland Hills Texas
Not listed San Antonio Texas
Not listed Falls Church Virginia
Not listed Virginia Beach Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00376181, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2010 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00376181 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →